Drug-induced retinopathies
Beraru, V.
Oftalmologia 50(3): 86-93
2006
ISSN/ISBN: 1220-0875 PMID: 17144513 Document Number: 597448
Drug-induced retinopathies are rare conditions produced by a large variety of medications. There are several specific patterns of retinal toxicity, which should be recognized and correlated with the clinical state.
Document emailed within 1 workday
Related Documents
Nishikaze, O. 1975: Drug-drug interaction and drug-induced interference with clinical laboratory test procedures--chairman's introductory remarks Rinsho Byori. Japanese Journal of Clinical Pathology 23(2): 75Cermanová, M.; Beno, P.; Králiková, L. 1977: Retinopathies in children with diabetes mellitus Ceskoslovenska Pediatrie 32(5): 276-278
Fetter, W.P.; Baerts, W.; Wildervanck de Blécourt-Devilée, M. 1988: Retinopathies in children with very low birth weight Nederlands Tijdschrift Voor Geneeskunde 132(35): 1613-1616
Lomícková, H.; Mydlil, V. 1973: Directives for the prevention of retinopathies in premature infants Ceskoslovenska Gynekologie 38(9): 712
Maciejewski, Z. 1974: Indications for xenon photocoagulation in diabetic retinopathies Wiadomosci Lekarskie 27(6): 527-530
Haicl, P. 1989: Cryoretinopexy in the treatment of proliferative diabetic retinopathies with hemophthalmos Ceskoslovenska Oftalmologie 45(4): 279-287
Silverstone, B.; Berson, D.; Eilat, U.; Kuperman, O. 1981: Copper metabolism changes in pigmentary retinopathies and high myopia Metabolic and Pediatric Ophthalmology 5(1): 49-53
Nigen, S.; Knowles, S.R.; Shear, N.H. 2003: Drug eruptions: approaching the diagnosis of drug-induced skin diseases Journal of Drugs in Dermatology: Jdd 2(3): 278-299
Bach, O.; Kästner, I. 1984: Undesired drug side effects and drug-induced damage. II. Centrally acting drugs Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 39(1): 1-6
Koriakin, V.A.; Sokolova, G.B.; Ziia, A.V.; Zeliger, L.R.; Ivleva, A.Ia. 1987: Pharmacokinetic bases for the drug-free prevention of drug-induced hepatitis in pulmonary tuberculosis patients Terapevticheskii Arkhiv 59(7): 75-77
Jennum, P.; Kristensen, M.B. 1985: Drug-induced blood dyscrasias. Reports to the Committee on Adverse Drug Reactions 1968-1983 Ugeskrift for Laeger 147(32): 2539-2541
Llau, M.E.; Nguyen, L.; Senard, J.M.; Rascol, O.; Montastruc, J.L. 1994: Drug-induced Parkinson syndrome: 10 years of drug vigilance Therapie 49(5): 459-460
Kourounakis, P.N.; Rekka, E.; Hadjipetrou-Kourounakis, L. 1991: Restoration of impaired drug metabolism of rats with adjuvant induced disease by two steroids with different influence on drug biotransformation Die Pharmazie 46(10): 727-729
Danilova, A.I.; Dekhtiareva, O.S. 1984: Cellular immunity in patients with diabetes mellitus complicated by diabetic retinopathies Problemy Endokrinologii 30(5): 29-34
Katayama, S. 2005: Renoprotective effect of Blood pressure control on progression of diabetic retinopathies Nihon Rinsho. Japanese Journal of Clinical Medicine 63 Suppl. 6: 389-393
Baliarda, R.A.; Laguens, R.; Puchulu, F.E.; Ruiz, M.; Courtis, J.M.; Marti, M.L.; Rodriguez, M.; Matianich, A. 1970: Diabetic microangiopathies. Anatomopathological study of the conjunctiva and skin, using optical and electron microscopy; correlation with retinopathies Prensa Medica Argentina 57(1): 30-42
Goldberg, M.F. 1972: Retinal detachment associated with proliferative retinopathies (sickle cell disease, retrolental fibroplasia and diabetes mellitus) Israel Journal of Medical Sciences 8(8): 1447-1457
Pissarek, D.; Schoder, O. 1988: Proliferative retinopathies in diabetes mellitus--cross sectional study in the Erfurd city and rural district Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 43(23): 662-666
Rodríguez de la Serna, A.; Díaz-Rubio, M. 1994: Multicenter clinical trial of zinc acexamate in the prevention of nonsteroidal antiinflammatory drug induced gastroenteropathy. Spanish Study Group on NSAID Induced Gastroenteropathy Prevention Journal of Rheumatology 21(5): 927-933
Andersson, M.L.; Böttiger, Y.; Lindh, J.D.; Wettermark, B.; Eiermann, B. 2013: Impact of the drug-drug interaction database SFINX on prevalence of potentially serious drug-drug interactions in primary health care European Journal of Clinical Pharmacology 69(3): 565-571